Patent Number: 8,822,442

Title: Somatostatin-dopamine chimeric analogs

Abstract: The invention features somatostatin-dopamine chimeric analogs and methods relating to their therapeutic use for the treatment of neoplasia, acromegaly, and other conditions.

Inventors: Dong; Zheng Xin (Holliston, MA), Culler; Michael Dewitt (Hopkinton, MA), Shen; Yeelena (Franklin, MA)

Assignee: Ipsen Pharma S.A.S.

International Classification: A01N 43/00 (20060101); A01N 43/42 (20060101); C07K 17/00 (20060101); A01N 43/40 (20060101); A01N 43/64 (20060101); A01N 43/36 (20060101); A61K 31/33 (20060101); A61K 38/00 (20060101); A61K 38/31 (20060101); A61K 38/12 (20060101); A61K 38/08 (20060101); A61K 31/44 (20060101); A61K 31/41 (20060101); A61K 31/40 (20060101); A61P 5/02 (20060101); A61P 35/00 (20060101); A61P 35/04 (20060101); C07K 14/655 (20060101); C07K 5/00 (20060101); C07K 16/00 (20060101)

Expiration Date: 9/02/12018